Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.67 |
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
| ▸ | GSR | P00390 | 1/20 | 0.56 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.54 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10869353 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL1882487 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL1888370 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL1881586 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL1872640 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL4017002 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL4020912 | 1.00 | GABRR1 (0.67) | GABRR1LTA4HGSRRNPEPCPB2 | |
| Hydrochloric Acid SCHEMBL7667351 | 0.98 | GABRR1 (0.64) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL39271 | 0.98 | GABRR1 (0.70) | GABRR1LTA4HGSRRNPEPCPB2 | |
| SCHEMBL17974330 | 0.98 | GABRR1 (0.70) | GABRR1LTA4HGSRRNPEPCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10329242-B2 | Process for purifying long chain amino acids | VITAWORKS IP, LLC (US) | 2019-06-25 | — | — | US | claimed |
| EP-1501784-B1 | INTEGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-7745652-B2 | Integrated chemical processes for industrial utilization of seed oils | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-06-29 | — | — | US | disclosed |
| US-7576227-B2 | Integrate chemical processes for industrial utilization of seed oils | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2009-08-18 | — | — | US | disclosed |
| US-20090143544-A1 | INTEGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-06-04 | — | — | US | disclosed |
| US-20080003288-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | disclosed |
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2005-07-14 | — | — | US | disclosed |
| EP-1501784-A1 | INTERGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003093215-A1 | INTERGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | disclosed |
| EP-0186083-A2 | N-(2-Hyxdroxyalkyl)-amino acids and their derivatives, process for their preparation and pharmaceutical compositions containing them | ASTA Pharma AG (DE) | 1986-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | ALOX12, SQLE, ALOX15 | GABRR1 2396/4885LTA4H 455/4885GSR 974/4885 |
| US-10329242-B2 | Process for purifying long chain amino acids | BCAT1, SLC43A1, BCAT2 | GABRR1 470/4885LTA4H 3866/4885GSR 3700/4885 |
| US-20090143544-A1 | INTEGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | ALOX12, SQLE, ALOX15 | GABRR1 2682/4885LTA4H 554/4885GSR 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.